Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Preclinical Development: Overview

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...

Clinical Trials: Overview

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...

Drug Discovery: Overview

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...

Clinical Trials

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Safety and immunogenicity of a cytomegalovirus (CMV) recombinant glycoprotein B (gB) vaccine in combination with polyacrylate or an emulsion-based adjuvants.

Vaccine·2026

Same author

The success of toll-like receptor 4 based vaccine adjuvants.

Vaccine·2025

Same author

Antibody avidity, persistence, and response to antigen recall: comparison of vaccine adjuvants.

NPJ vaccines·2021

Same author

Safety biomarkers for development of vaccines and biologics: Report from the safety biomarkers symposium held on November 28-29, 2017, Marcy l'Etoile, France.

Vaccine·2020

Same author

Bulletin de l'Academie nationale de medecine·2020

Same author

The science of vaccine safety: Summary of meeting at Wellcome Trust.

Vaccine·2020

Search research articles

Related Experiment Video

Updated: Jun 16, 2026

Lumbar Intrathecal Injection of SOD1-ASOs for Precise CNS Targeting and Predictive Efficacy in Human SOD1-G93A ALS Mice

Lumbar Intrathecal Injection of SOD1-ASOs for Precise CNS Targeting and Predictive Efficacy in Human SOD1-G93A ALS Mice

Published on: February 24, 2026

Preclinical development of AS04.

Nathalie Garçon¹

¹Global Adjuvant Center for Vaccine, GlaxoSmithKline Biologicals, Wavre, Belgium. nathalie.garcon@gskbio.com

Methods in Molecular Biology (Clifton, N.J.)

|January 26, 2010

Summary

Preclinical studies show that the AS04 adjuvant system, combining aluminum salts and monophosphoryl lipid A (MPL), enhances vaccine-induced antibody and memory B cell responses. This makes AS04 effective for vaccines requiring high, long-lasting immunity.

Area of Science:

Immunology
Vaccinology

Background:

Vaccine Adjuvant Systems (AS) are developed to enhance vaccine efficacy.
AS04, developed by GlaxoSmithKline Biologicals, combines aluminum salts with monophosphoryl lipid A (MPL).
MPL is a detoxified lipid A derivative that retains immunostimulatory capacity with reduced pro-inflammatory cytokine induction compared to lipopolysaccharide (LPS).

Purpose of the Study:

To detail the preclinical evaluation methods for the AS04 adjuvant system.
To assess the contribution of MPL to AS04's immunostimulatory properties.
To demonstrate the effectiveness of AS04 in eliciting robust and durable immune responses.

Main Methods:

Preclinical evaluation of AS04 formulations.
Determination of optimal particle size for MPL.

More Related Videos

Direct Intraventricular Delivery of Drugs to the Rodent Central Nervous System

Direct Intraventricular Delivery of Drugs to the Rodent Central Nervous System

Published on: May 12, 2013

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo

Published on: September 28, 2022

Related Experiment Videos

Last Updated: Jun 16, 2026

Lumbar Intrathecal Injection of SOD1-ASOs for Precise CNS Targeting and Predictive Efficacy in Human SOD1-G93A ALS Mice

Lumbar Intrathecal Injection of SOD1-ASOs for Precise CNS Targeting and Predictive Efficacy in Human SOD1-G93A ALS Mice

Published on: February 24, 2026

Direct Intraventricular Delivery of Drugs to the Rodent Central Nervous System

Direct Intraventricular Delivery of Drugs to the Rodent Central Nervous System

Published on: May 12, 2013

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo

Published on: September 28, 2022

Comparative analysis of immune responses induced by AS04 versus aluminum salts alone.

Main Results:

AS04, containing MPL and aluminum salts, demonstrated superior vaccine-elicited antibody responses compared to aluminum salts alone.
Higher levels of memory B cells were induced by AS04 formulations.
Preclinical data supported the use of AS04 for achieving high and long-lasting antibody levels.

Conclusions:

AS04 is a tailored adjuvant system that significantly enhances vaccine-induced immune responses.
The inclusion of MPL in AS04 is crucial for boosting antibody and memory B cell induction.
AS04 preclinical evaluation provides a strong basis for its successful application in vaccines such as those against hepatitis B and human papillomavirus.